⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DXCM News
DexCom, Inc.
Shareholders of DexCom, Inc. (DXCM): Protect Your Rights Before December 26, 2025 - Contact Levi & Korsinsky
accessnewswire.com
DXCM
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
businesswire.com
DXCM
Securities Lawsuit Alert: DexCom, Inc. (DXCM) - Contact Levi & Korsinsky Before December 26, 2025
accessnewswire.com
DXCM
Pomerantz LLP Files Securities Class Action Lawsuit Against DexCom, Inc. – DXCM
accessnewswire.com
DXCM
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
DXCM
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
DXCM
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
DXCM
December 26, 2025 Deadline: Join Class Action Lawsuit Against DexCom, Inc. (DXCM) - Contact Levi & Korsinsky
accessnewswire.com
DXCM
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors - Lead Plaintiff Deadline December 26, 2025
accessnewswire.com
DXCM
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
prnewswire.com
DXCM